Venturi Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

Venturi Wealth Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$396K	Sell	24,709 -1,079	-4%	-$17.9K	0.02%	432
2026 Q1	$478K	Buy	25,788 +2,337	+10%	+$41K	0.02%	358
2025 Q4	$366K	Buy	23,451 +8,540	+57%	+$122K	0.02%	418
2025 Q3	$218K	Buy	14,911 +2,459	+20%	+$36.5K	0.01%	528
2025 Q2	$193K	Buy	+12,452	New	+$184K	0.01%	525
2025 Q1	–	Sell	-5,028	Closed	-$66.6K	–	1678
2024 Q4	$66.6K	Buy	5,028 +4,260	+555%	+$58.5K	﹤0.01%	935
2024 Q3	$10.9K	Buy	768 +97	+14%	+$1.38K	﹤0.01%	1168
2024 Q2	$8.68K	Buy	+671	New	+$8.88K	﹤0.01%	1132
2023 Q4	–	Sell	-100	Closed	-$1.55K	–	1432
2023 Q3	$1.55K	Buy	+100	New	+$1.55K	﹤0.01%	1222

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Venturi Wealth Management's TAK Position: Q2 2026 in Review

Venturi Wealth Management reduced its Takeda Pharmaceutical (TAK) stake by 4.2% in Q2 2026, selling an estimated $17.9K and leaving 24,709 shares worth $396K. The position accounts for 0.02% of the portfolio, ranked #432.

Venturi Wealth Management first reported a position in TAK in Q3 2023 and has held it in 9 quarters since. The position peaked at $478K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Venturi Wealth Management held 24,709 shares of Takeda Pharmaceutical worth $396K as of Q2 2026.
Venturi Wealth Management sold 1,079 Takeda Pharmaceutical shares in Q2 2026, an estimated $17.9K.
Takeda Pharmaceutical made up 0.02% of Venturi Wealth Management's portfolio in Q2 2026, its #432 holding.
Venturi Wealth Management first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 9 quarters since.
Venturi Wealth Management's Takeda Pharmaceutical position peaked at $478K in Q1 2026.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.